NCT02442791View on ClinicalTrials.gov

GLP-1 Analogs for Neuroprotection After Cardiac Arrest

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Cardiac ArrestComa
Interventions
DRUG

Byetta (Lilly, Exenatide)

See description of Arms

OTHER

20% Human Albumin

See description of Arms

Trial Locations (1)

DK-2100

Kardiologisk Afdeling, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Jesper Kjaergaard

OTHER

NCT02442791 - GLP-1 Analogs for Neuroprotection After Cardiac Arrest | Biotech Hunter | Biotech Hunter